Tudor Investment Corp
EWTX icon

Tudor Investment Corp’s Edgewise Therapeutics EWTX Stock Holding History

Tudor Investment Corp’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$942K Buy
+29,889
New +$862K ﹤0.01% 2414
2025
Q3 		– Sell
-41,663
Closed -$591K – 3487
2025
Q2 		$546K Sell
41,663
-5,141
-11% -$74.1K ﹤0.01% 2543
2025
Q1 		$1.03M Buy
46,804
+2,995
+7% +$78.6K ﹤0.01% 1786
2024
Q4 		$1.17M Buy
43,809
+8,196
+23% +$261K ﹤0.01% 1619
2024
Q3 		$951K Buy
35,613
+9,203
+35% +$183K ﹤0.01% 1650
2024
Q2 		$476K Buy
+26,410
New +$461K ﹤0.01% 1825

Other funds holding EWTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Tudor Investment Corp's EWTX Position: Q1 2026 in Review

Tudor Investment Corp opened a new position in Edgewise Therapeutics (EWTX) in Q1 2026: 29,889 shares worth $942K. The stake represents ﹤0.01% of the portfolio and ranks #2414 among its holdings. This is a return to the name: Tudor Investment Corp previously reported a position in EWTX as recently as Q2 2025.

Tudor Investment Corp first reported a position in EWTX in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.17M in Q4 2024. 214 funds tracked by Wall St. Rank hold EWTX as of Q1 2026.

  • Tudor Investment Corp held 29,889 shares of Edgewise Therapeutics worth $942K as of Q1 2026.
  • Edgewise Therapeutics was a new Tudor Investment Corp position in Q1 2026.
  • Edgewise Therapeutics made up ﹤0.01% of Tudor Investment Corp's portfolio in Q1 2026, its #2414 holding.
  • Tudor Investment Corp first reported a position in Edgewise Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Tudor Investment Corp's Edgewise Therapeutics position peaked at $1.17M in Q4 2024.
  • 214 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.